Use of depth of response to predict progression ‐free survival in relapsed or refractory multiple myeloma: Evaluation of results from 102 clinical trials

Hematological Oncology, EarlyView.

Source: Hematological Oncology - April 19, 2018 Category: Hematology Authors: NaveenMangal , Ahmed HamedSalem , Rajeev M.Menon , Kevin J.Freise Source Type: research